ZACKS ANDREW 4
4 · MAXYGEN INC · Filed Dec 29, 2009
Insider Transaction Report
Form 4
MAXYGEN INCMAXY
CONUS PARTNERS INC
10% Owner
Transactions
- Sale
Common Stock
2009-12-24$5.31/sh−900$4,779→ 4,368,842 total(indirect: See footnote) - Sale
Common Stock
2009-12-24$5.50/sh−200$1,100→ 4,368,042 total(indirect: See footnote) - Sale
Common Stock
2009-12-24$5.30/sh−198,200$1,050,460→ 4,369,742 total(indirect: See footnote) - Sale
Common Stock
2009-12-24$5.32/sh−500$2,660→ 4,368,342 total(indirect: See footnote) - Sale
Common Stock
2009-12-24$5.35/sh−100$535→ 4,368,242 total(indirect: See footnote) - Sale
Common Stock
2009-12-24$5.63/sh−100$563→ 4,367,942 total(indirect: See footnote)
Footnotes (1)
- [F1]These shares of Common Stock (the "Shares") of Maxygen, Inc. (the "Issuer") are held in the accounts of private investment vehicles and certain managed accounts over which Conus Partners, Inc. and Andrew Zacks (the "Reporting Persons") each has investment discretion. Conus Partners, Inc. has investment discretion over the Shares because it is the investment adviser to such private investment vehicles and managed accounts. Andrew Zacks has investment discretion over the Shares because he is the managing director of Conus Partners, Inc.